The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD
Clinical trial NCT06633042 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06633042
- Sponsor
- Bioray Laboratories
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-25
- Primary completion
- 2025-10-12
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.